FDA approves obesity drug that helped people cut weight 15%

[apnews.com – 2021.06.04] Regulators on Friday said a new version of a popular diabetes medicine could be sold as a weight-loss drug in the U.S. The Food and Drug Administration approved Wegovy, a higher-dose version of Novo Nordisk’s diabetes drug semaglutide, for long-term weight management.   In company-funded studies, participants taking Wegovy had average weight loss […]

FDA approves obesity drug that helped people cut weight 15% Read More »